Lundbeck's Migraine Therapy Vyepti: Overcoming The COVID-19 Effect
Northera Suffers Generic Erosion In First Quarter
Denmark’s Lundbeck is aiming to build up use of its latest neurological, the long-acting migraine preventative, Vyepti, now that US healthcare is emerging from COVID-19-related restrictions, but is facing headwinds from loss of exclusivity on Northera.
